U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of Policy, Legislation, and International Affairs
  1. Office of the Commissioner

Office of Policy, Legislation, and International Affairs

Effective March 31, 2019, FDA began operational implementation of an agency reorganization. FDA’s reorganization reflects the agency’s commitment to modernizing its structure to advance its mission to protect and promote public health, and to meet the challenges of rapid innovation across the industries regulated by FDA. FDA's reorganization realigns several entities across the agency to promote strategic priorities, and elevates the role of the centers, offices and field forces.

This organization chart reflects the new structure.

Andi Lipstein Fristedt
Deputy Commissioner

Beethika Khan, Ph.D.
Associate Commissioner for Economics and Analysis 
Office of Economics and Analysis

Andrew Tantillo, J.D. 
Acting Associate Commissioner for Legislative Affairs 
Office of Legislation

Maren McBride
Director of Congressional Appropriations
Office of Congressional Appropriations

Mark Abdoo
Associate Commissioner for Global Policy and Strategy 
Office of Global Policy and Strategy

Lauren Roth, J.D.
Associate Commissioner for Policy
Office of Policy

Linda Fobbs
Director of Management and Operations 
Management and Operations Staff

Nicholas Alexander, J.D.
Director of Intergovernmental Affairs 
Intergovernmental Affairs Staff



Back to Top